Summary

Commonly reported side effects of secukinumab include: infection and nasopharyngitis. Other side effects include: diarrhea. Continue reading for a comprehensive list of adverse effects.

Applies to secukinumab: parenteral injection, parenteral powder for injection.

Side effects include:

Adverse effects reported in ≥1% of patients receiving secukinumab include nasopharyngitis, diarrhea, and upper respiratory tract infection.

For Healthcare Professionals

Applies to secukinumab: subcutaneous powder for injection, subcutaneous solution.

Dermatologic

Uncommon (0.1% to 1%): Tinea pedis, urticaria^[Ref]

Gastrointestinal

Common (1% to 10%): Diarrhea, oral herpes

Uncommon (0.1% to 1%): Oral candidiasis

Frequency not reported: Exacerbation of inflammatory bowel disease (IBD)^[Ref]

Hypersensitivity

Rare (less than 0.1%): Anaphylaxis^[Ref]

Immunologic

Uncommon (0.1% to 1%): Immunogenicity

Frequency not reported: Candida infections, herpes viral infections, staphylococcal skin infections, infections requiring treatment (increased as serum concentration of this drug is increased), neutropenia^[Ref]

Respiratory

Very common (10% or more): Nasopharyngitis (11%)

Common (1% to 10%): Upper respiratory tract infection, rhinitis, pharyngitis, rhinorrhea^[Ref]

Hematologic

Uncommon (0.1% to 1%): Neutropenia^[Ref]

Ocular

Uncommon (0.1% to 1%): Conjunctivitis^[Ref]

Other

Uncommon (0.1% to 1%): Otitis externa^[Ref]